Comparative study of superparamagnetic iron oxide/doxorubicin co-loaded poly (lactic-co-glycolic acid) nanospheres prepared by different emulsion solvent evaporation methods

References

• Chen Z. Small-molecule delivery by nanoparticles for anticancer therapy. Trends Mol Med. 2010;16:594–602.
   PubMed Web of Science ®Google Scholar
• Vrignaud S, Benoit J-P, Saulnier P. Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles. Biomaterials. 2011;32:8593–8604.
   PubMed Web of Science ®Google Scholar
• Zafar N, Fessi H, Elaissari A. Cyclodextrin containing biodegradable particles: from preparation to drug delivery applications. Int J Pharm. 2014;461:351–366.
   PubMed Web of Science ®Google Scholar
• Jahanshahi M, Babaei Z. Protein nanoparticle: a unique system as drug delivery vehicles. Afr J Biotechnol. 2008;7:4926–4934.
   Web of Science ®Google Scholar
• Sah H, Thoma LA, Desu HR, et al. Concepts and practices used to develop functional PLGA-based nanoparticulate systems. Int J Nanomed. 2013;8:747.
   PubMed Web of Science ®Google Scholar
• Danhier F, Ansorena E, Silva JM, et al. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release. 2012;161:505–522.
   PubMed Web of Science ®Google Scholar
• Iqbal M, Zafar N, Fessi H, et al. Double emulsion solvent evaporation techniques used for drug encapsulation. Int J Pharm. 2015;496:173–190.
   PubMed Web of Science ®Google Scholar
• Boisdron-Celle M, Menei P, Benoit J. Preparation and characterization of 5‐fluorouracil‐loaded microparticles as biodegradable anticancer drug carriers. J Pharm Pharmacol. 1995;47:108–114.
   PubMed Web of Science ®Google Scholar
• Verrijk R, Smolders IJ, Bosnie N, et al. Reduction of systemic exposure and toxicity of cisplatin by encapsulation in poly-lactide-co-glycolide. Cancer Res. 1992;52:6653–6656.
   PubMed Web of Science ®Google Scholar
• Garti N, Bisperink C. Double emulsions: progress and applications. Curr Opin Colloid Interface Sci. 1998;3:657–667.
   Web of Science ®Google Scholar
• Siegfried A. Angleterre d’aujourd’hui; 1924.
   Google Scholar
• Schuch A, Deiters P, Henne J, et al. Production of W/O/W (water-in-oil-in-water) multiple emulsions: droplet breakup and release of water. J Colloid Interface Sci. 2013;402:157–164.
   PubMed Web of Science ®Google Scholar
• Okochi H, Nakano M. Preparation and evaluation of w/o/w type emulsions containing vancomycin. Adv Drug Deliv Rev. 2000;45:5–26.
   PubMed Web of Science ®Google Scholar
• Sinha V, Trehan A. Biodegradable microspheres for protein delivery. J Control Release. 2003;90:261–280.
   PubMed Web of Science ®Google Scholar
• Florence A, Whitehill D. Some features of breakdown in water-in-oil-in-water multiple emulsions. J Colloid Interface Sci. 1981;79:243–256.
   Web of Science ®Google Scholar
• Ramazani F, Chen W, van Nostrum CF, et al. Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: state-of-the-art and challenges. Int J Pharm. 2016;499:358–367.
   PubMed Web of Science ®Google Scholar
• Falke LL, van Vuuren SH, Kazazi-Hyseni F, et al. Local therapeutic efficacy with reduced systemic side effects by rapamycin-loaded subcapsular microspheres. Biomaterials. 2015;42:151–160.
   PubMed Web of Science ®Google Scholar
• Kazazi-Hyseni F, Landin M, Lathuile A, et al. Computer modeling assisted design of monodisperse PLGA microspheres with controlled porosity affords zero order release of an encapsulated macromolecule for 3 months. Pharm Res. 2014;31:2844–2856.
   PubMed Web of Science ®Google Scholar
• Ramazani F, Chen W, Van Nostrum CF, et al. Formulation and characterization of microspheres loaded with imatinib for sustained delivery. Int J Pharm. 2015;482:123–130.
   PubMed Web of Science ®Google Scholar
• Xu Q, Hashimoto M, Dang TT, et al. Preparation of monodisperse biodegradable polymer microparticles using a microfluidic flow‐focusing device for controlled drug delivery. Small. 2009;5:1575–1581.
   PubMed Web of Science ®Google Scholar
• Ye M, Kim S, Park K. Issues in long-term protein delivery using biodegradable microparticles. J Control Release. 2010;146:241–260.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Bi X, Li H, et al. Enhanced targeting efficiency of PLGA microspheres loaded with Lornoxicam for intra-articular administration. Drug Deliv. 2011;18:536–544.
   PubMed Web of Science ®Google Scholar
• Li M, Rouaud O, Poncelet D. Microencapsulation by solvent evaporation: state of the art for process engineering approaches. Int J Pharm. 2008;363:26–39.
   PubMed Web of Science ®Google Scholar
• Qi F, Wu J, Hao D, et al. Comparative studies on the influences of primary emulsion preparation on properties of uniform-sized exenatide-loaded PLGA microspheres. Pharm Res. 2014;31:1566–1574.
   PubMed Web of Science ®Google Scholar
• Vladisavljević GT, Schubert H. Influence of process parameters on droplet size distribution in SPG membrane emulsification and stability of prepared emulsion droplets. J Membr Sci. 2003;225:15–23.
   Web of Science ®Google Scholar
• Liu D, Mori A, Huang L. Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM 1-containing liposomes. Biochim Biophys Acta (BBA)-Biomembr. 1992;1104:95–101.
   PubMed Web of Science ®Google Scholar
• Guo J, Gao X, Su L, et al. Aptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug delivery. Biomaterials. 2011;32:8010–8020.
   PubMed Web of Science ®Google Scholar
• Dhar S, Gu FX, Langer R, et al. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt (IV) prodrug-PLGA–PEG nanoparticles. Proc Natl Acad Sci. 2008;105:17356–17361.
   PubMed Web of Science ®Google Scholar
• Ling Y, Wei K, Zou F, et al. Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma. Int J Pharm. 2012;430:266–275.
   PubMed Web of Science ®Google Scholar
• Ling Y, Wei K, Luo Y, et al. Dual docetaxel/superparamagnetic iron oxide loaded nanoparticles for both targeting magnetic resonance imaging and cancer therapy. Biomaterials. 2011;32:7139–7150.
   PubMed Web of Science ®Google Scholar
• Carvalho C, Santos RX, Cardoso S, et al. Doxorubicin: the good, the bad and the ugly effect. CMC. 2009;16:3267–3285.
   PubMed Web of Science ®Google Scholar
• Xu W-H, Han M, Dong Q, et al. Doxorubicin-mediated radiosensitivity in multicellular spheroids from a lung cancer cell line is enhanced by composite micelle encapsulation. Int J Nanomed. 2012;7:2661.
   PubMed Web of Science ®Google Scholar
• Blay J-Y, Leahy MG, Nguyen BB, et al. Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas. Eur J Cancer. 2014;50:1137–1147.
   PubMed Web of Science ®Google Scholar
• Xu Q, Leong J, Chua QY, et al. Combined modality doxorubicin-based chemotherapy and chitosan-mediated p53 gene therapy using double-walled microspheres for treatment of human hepatocellular carcinoma. Biomaterials. 2013;34:5149–5162.
   PubMed Web of Science ®Google Scholar
• Hiddemann W, Kneba M, Dreyling M, et al. Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. Blood. 2005;106:3725–3732.
   PubMed Web of Science ®Google Scholar
• Mao JN, Li AJ, Zhao LP, et al. PEG-PLGA nanoparticles entrapping doxorubicin reduced doxorubicin-induced cardiotoxicity in rats. Adv Mater Res. 2014;912:263–268.
   Google Scholar
• Wu W, Wu Z, Yu T, et al. Recent progress on magnetic iron oxide nanoparticles: synthesis, surface functional strategies and biomedical applications. Sci Technol Adv Mater. 2016;16:023501.
   Web of Science ®Google Scholar
• Yigit MV, Moore A, Medarova Z. Magnetic nanoparticles for cancer diagnosis and therapy. Pharm Res. 2012;29:1180–1188.
   PubMed Web of Science ®Google Scholar
• Mosafer J, Abnousb K, Tafaghodi M, et al. Preparation and characterization of uniform-sized PLGA nanospheres encapsulated with oleic acid-coated magnetic-Fe 3 O 4 nanoparticles for simultaneous diagnostic and therapeutic applications. Colloids Surf A: Physicochem Eng Aspects. 2017;514:146–154.
   Web of Science ®Google Scholar
• Mosafer J, Teymouri M, Abnous K, et al. Study and evaluation of nucleolin-targeted delivery of magnetic PLGA-PEG nanospheres loaded with doxorubicin to C6 glioma cells compared with low nucleolin-expressing L929 cells. Mater Sci Eng C. 2017;72:123–133.
   PubMed Web of Science ®Google Scholar
• Mosafer J, Abnous K, Tafaghodi M, et al. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy. Eur J Pharm Biopharm. 2017;113:60–74.
   PubMed Web of Science ®Google Scholar
• Wohlfart S, Khalansky AS, Gelperina S, et al. Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers. PLoS One. 2011;6:e19121.
   PubMed Web of Science ®Google Scholar
• Alibolandi M, Ramezani M, Abnous K, et al. In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer. J Control Release. 2015;209:88–100.
   PubMed Web of Science ®Google Scholar
• Tewes F, Munnier E, Antoon B, et al. Comparative study of doxorubicin-loaded poly (lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods. Eur J Pharm Biopharm. 2007;66:488–492.
   PubMed Web of Science ®Google Scholar
• Sanson C, Schatz C, Le Meins JF, et al. A simple method to achieve high doxorubicin loading in biodegradable polymersomes. J Control Release. 2010;147:428–435.
   PubMed Web of Science ®Google Scholar
• Kataoka K, Matsumoto T, Yokoyama M, et al. Doxorubicin-loaded poly (ethylene glycol)–poly (β-benzyl-l-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. J Control Release. 2000;64:143–153.
   PubMed Web of Science ®Google Scholar
• Khemani M, Sharon M, Sharon M. pH dependent encapsulation of doxorubicin in PLGA. Ann Biol Res. 2012;3:4414–4419.
   Google Scholar
• Raghunand N, Mahoney BP, Gillies RJ. Tumor acidity, ion trapping and chemotherapeutics: II. pH-dependent partition coefficients predict importance of ion trapping on pharmacokinetics of weakly basic chemotherapeutic agents. Biochem Pharmacol. 2003;66:1219–1229.
   PubMed Web of Science ®Google Scholar
• Cheung BC, Sun TH, Leenhouts JM, et al. Loading of doxorubicin into liposomes by forming Mn 2+-drug complexes. Biochim Biophys Acta (BBA)-Biomembr. 1998;1414:205–216.
   PubMed Web of Science ®Google Scholar
• Acharya S, Sahoo SK. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev. 2011;63:170–183.
   PubMed Web of Science ®Google Scholar
• Magenheim B, Levy M, Benita S. A new in vitro technique for the evaluation of drug release profile from colloidal carriers-ultrafiltration technique at low pressure. Int J Pharm. 1993;94:115–123.
   Web of Science ®Google Scholar
• Hu F, Neoh K, Kang E. Synthesis and in vitro anti-cancer evaluation of tamoxifen-loaded magnetite/PLLA composite nanoparticles. Biomaterials. 2006;27:5725–5733.
   PubMed Web of Science ®Google Scholar
• Cui Y, Xu Q, Chow PK, et al. Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment. Biomaterials. 2013;34:8511–8520.
   PubMed Web of Science ®Google Scholar